Repro Med Systems Stock Fundamentals
Repro Med Systems fundamentals help investors to digest information that contributes to Repro Med's financial success or failures. It also enables traders to predict the movement of Repro OTC Stock. The fundamental analysis module provides a way to measure Repro Med's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Repro Med otc stock.
Repro |
Repro Med Systems OTC Stock Return On Equity Analysis
Repro Med's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Repro Med Return On Equity | 0.27 |
Most of Repro Med's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Repro Med Systems is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Repro Med Systems has a Return On Equity of 0.27. This is 101.13% lower than that of the Healthcare sector and 104.52% lower than that of the Medical Instruments & Supplies industry. The return on equity for all United States stocks is 187.1% lower than that of the firm.
Repro Med Systems Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Repro Med's current stock value. Our valuation model uses many indicators to compare Repro Med value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Repro Med competition to find correlations between indicators driving Repro Med's intrinsic value. More Info.Repro Med Systems is currently regarded as top stock in return on equity category among related companies. It is currently regarded as top stock in return on asset category among related companies reporting about 39.52 of Return On Asset per Return On Equity. Comparative valuation analysis is a catch-all model that can be used if you cannot value Repro Med by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Repro Med's OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Repro Med's earnings, one of the primary drivers of an investment's value.Repro Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Repro Med's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Repro Med could also be used in its relative valuation, which is a method of valuing Repro Med by comparing valuation metrics of similar companies.Repro Med is currently under evaluation in return on equity category among related companies.
Repro Fundamentals
| Return On Equity | 0.27 | |||
| Return On Asset | 10.67 | |||
| Profit Margin | 0.13 % | |||
| Operating Margin | 9.81 % | |||
| Current Valuation | 131.75 M | |||
| Shares Outstanding | 38.38 M | |||
| Shares Owned By Insiders | 44.43 % | |||
| Shares Owned By Institutions | 17.96 % | |||
| Price To Earning | 393.75 X | |||
| Price To Book | 16.13 X | |||
| Price To Sales | 8.02 X | |||
| Revenue | 19.14 M | |||
| Gross Profit | 10.81 M | |||
| EBITDA | 2.21 M | |||
| Net Income | 24.21 K | |||
| Cash And Equivalents | 3.81 M | |||
| Cash Per Share | 0.10 X | |||
| Total Debt | 444.08 K | |||
| Debt To Equity | 4.60 % | |||
| Current Ratio | 5.30 X | |||
| Book Value Per Share | 0.25 X | |||
| Cash Flow From Operations | (960.03 K) | |||
| Number Of Employees | 75 | |||
| Beta | 0.03 | |||
| Market Capitalization | 153.54 M | |||
| Total Asset | 8.34 M | |||
| Retained Earnings | 3.02 M | |||
| Working Capital | 5.6 M | |||
| Current Asset | 7.01 M | |||
| Current Liabilities | 1.41 M |
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Consideration for investing in Repro OTC Stock
If you are still planning to invest in Repro Med Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Repro Med's history and understand the potential risks before investing.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |